| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |